Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)
Condition(s):Leukemia, Myelocytic, AcuteLast Updated:February 2, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):Leukemia, Myelocytic, AcuteLast Updated:February 2, 2010Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:February 2, 2024Completed
Condition(s):Acute Promyelocytic LeukemiaLast Updated:March 31, 2008Completed
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:October 20, 2020Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:May 5, 2020Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:April 7, 2014Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:June 4, 2020Completed
Condition(s):Localized Non-Resectable Adult Hepatocellular CarcinomaLast Updated:August 19, 2016Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:March 22, 2019Unknown status
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:August 21, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.